Literature DB >> 8725106

Glycoprotein B (gB) of pseudorabies virus interacts specifically with the glycosaminoglycan heparin.

D Sawitzky1, A Voigt, H Zeichhardt, K O Habermehl.   

Abstract

We have previously shown that the pseudorabies virus (PrV) glycoproteins gB and gC (former PrV-gII and PrV-gIII) exhibit heparin-binding properties. While PrV-gC functions as the major adsorption protein, the biological role of the heparin-binding properties of PrV-gB are not understood. We used a gC-deleted PrV-mutant, PrV (dlg92/dltk), to analyse the heparin-binding properties of PrV-gB and the biological role of the PrV-gB-protein in adsorption. PrV-gB was the only glycoprotein of this vaccine strain binding to immobilised heparin in in vitro assays. Presence of the gC-protein was not necessary for the interaction of gB with heparin. Soluble heparin also interfered with adsorption of this mutant virus to a similar extent as it blocked adsorption of wild-type PrV (Ka), but it had only a minor inhibitory effect on infectivity of the mutant strain. These results show that PrV-gB interacts specifically with immobilized heparin and heparin-like structures on the cell surface, but this interaction is not required for a productive infection.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8725106     DOI: 10.1016/0168-1702(95)01277-x

Source DB:  PubMed          Journal:  Virus Res        ISSN: 0168-1702            Impact factor:   3.303


  2 in total

1.  Bovine herpesvirus 1 glycoprotein B does not productively interact with cell surface heparan sulfate in a pseudorabies virion background.

Authors:  B G Klupp; A Karger; T C Mettenleiter
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

2.  The pseudorabies virus UL11 protein is a virion component involved in secondary envelopment in the cytoplasm.

Authors:  Martina Kopp; Harald Granzow; Walter Fuchs; Barbara G Klupp; Egbert Mundt; Axel Karger; Thomas C Mettenleiter
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.